Devon Cayer active positions
Companies | Position | Start | End |
---|---|---|---|
Myi Diagnostics & Discovery, Inc.
Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 08/09/2015 | - |
Founder | 08/09/2015 | - |
Career history of Devon Cayer
Former positions of Devon Cayer
Companies | Position | Start | End |
---|---|---|---|
1859, Inc.
1859, Inc. BiotechnologyHealth Technology 1859, Inc. operates as a biotechnology company focuses on discovery and development of next-generation therapeutics. The company was founded by Devon Cayer, Andrew MacConnell, Ramesh Ramji, and Sara Thrall and is headquartered in Del Mar, CA. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Founder | - | - |
Statistics
International
United States | 3 |
Operational
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Myi Diagnostics & Discovery, Inc.
Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Health Technology |
1859, Inc.
1859, Inc. BiotechnologyHealth Technology 1859, Inc. operates as a biotechnology company focuses on discovery and development of next-generation therapeutics. The company was founded by Devon Cayer, Andrew MacConnell, Ramesh Ramji, and Sara Thrall and is headquartered in Del Mar, CA. | Health Technology |
- Stock Market
- Insiders
- Devon Cayer
- Experience